282 related articles for article (PubMed ID: 2715168)
41. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907
[TBL] [Abstract][Full Text] [Related]
42. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
Sasaki T; Lopes MB; Hankins GR; Helm GA
Acta Neuropathol; 2002 Jul; 104(1):105-9. PubMed ID: 12070671
[TBL] [Abstract][Full Text] [Related]
43. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
44. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
Hoshino T; Nagashima T; Murovic JA; Wilson CB; Edwards MS; Gutin PH; Davis RL; DeArmond SJ
J Neurosurg; 1986 Mar; 64(3):453-9. PubMed ID: 3950723
[TBL] [Abstract][Full Text] [Related]
45. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
[TBL] [Abstract][Full Text] [Related]
46. Tenascin expression in astrocytomas correlates with angiogenesis.
Zagzag D; Friedlander DR; Miller DC; Dosik J; Cangiarella J; Kostianovsky M; Cohen H; Grumet M; Greco MA
Cancer Res; 1995 Feb; 55(4):907-14. PubMed ID: 7531617
[TBL] [Abstract][Full Text] [Related]
47. Expression of neu/c-erbB-2 in human brain tumors.
Schwechheimer K; Läufle RM; Schmahl W; Knödlseder M; Fischer H; Höfler H
Hum Pathol; 1994 Aug; 25(8):772-80. PubMed ID: 7914508
[TBL] [Abstract][Full Text] [Related]
48. Application of different methods for nuclear shape analysis with special reference to the differentiation of brain tumors.
Nafe R; Yan B; Schlote W; Schneider B
Anal Quant Cytol Histol; 2006 Apr; 28(2):69-77. PubMed ID: 16637509
[TBL] [Abstract][Full Text] [Related]
49. Magnetic resonance spectroscopy in intracranial tumours of glial origin.
Jaskólski DJ; Fortuniak J; Majos A; Gajewicz W; Papierz W; Liberski PP; Sikorska B; Stefańczyk L
Neurol Neurochir Pol; 2013; 47(5):438-49. PubMed ID: 24166565
[TBL] [Abstract][Full Text] [Related]
50. Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas.
Haapasalo J; Mennander A; Helen P; Haapasalo H; Isola J
J Clin Pathol; 2005 Mar; 58(3):263-8. PubMed ID: 15735157
[TBL] [Abstract][Full Text] [Related]
51. alpha(v)beta(3) Integrin in central nervous system tumors.
Lim M; Guccione S; Haddix T; Sims L; Cheshier S; Chu P; Vogel H; Harsh G
Hum Pathol; 2005 Jun; 36(6):665-9. PubMed ID: 16021573
[TBL] [Abstract][Full Text] [Related]
52. Oligodendroglioma: pathology and molecular biology.
Engelhard HH; Stelea A; Cochran EJ
Surg Neurol; 2002 Aug; 58(2):111-7; discussion 117. PubMed ID: 12453646
[TBL] [Abstract][Full Text] [Related]
53. Pleiotrophin expression in astrocytic and oligodendroglial tumors and it's correlation with histological diagnosis, microvascular density, cellular proliferation and overall survival.
Peria FM; Neder L; Marie SK; Rosemberg S; Oba-Shinjo SM; Colli BO; Gabbai AA; Malheiros SM; Zago MA; Panepucci RA; Moreira-Filho CA; Okamoto OK; Carlotti CG
J Neurooncol; 2007 Sep; 84(3):255-61. PubMed ID: 17443289
[TBL] [Abstract][Full Text] [Related]
54. Pathologic analysis of primary brain tumors.
McComb RD; Burger PC
Neurol Clin; 1985 Nov; 3(4):711-28. PubMed ID: 3001488
[TBL] [Abstract][Full Text] [Related]
55. Progression of astrocytomas and meningiomas: an evaluation in vitro.
Maes L; Kalala JP; Cornelissen M; de Ridder L
Cell Prolif; 2007 Feb; 40(1):14-23. PubMed ID: 17227292
[TBL] [Abstract][Full Text] [Related]
56. Karyometric features of low and high grade glial tumors as compared with their MRI appearance.
Scarpelli M; Montironi R; Salvolini U; Messori A; Bartels PH
Anal Quant Cytol Histol; 2004 Apr; 26(2):87-96. PubMed ID: 15131896
[TBL] [Abstract][Full Text] [Related]
57. Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours.
Kordek R; Biernat W; Alwasiak J; Liberski PP
Acta Neurochir (Wien); 1996; 138(5):509-12; discussion 513. PubMed ID: 8800324
[TBL] [Abstract][Full Text] [Related]
58. Aberrant localization of the neuronal class III beta-tubulin in astrocytomas.
Katsetos CD; Del Valle L; Geddes JF; Assimakopoulou M; Legido A; Boyd JC; Balin B; Parikh NA; Maraziotis T; de Chadarevian JP; Varakis JN; Matsas R; Spano A; Frankfurter A; Herman MM; Khalili K
Arch Pathol Lab Med; 2001 May; 125(5):613-24. PubMed ID: 11300931
[TBL] [Abstract][Full Text] [Related]
59. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas.
Kordek R; Biernat W; Debiec-Rychter M; Alwasiak J; Liberski PP
Pathol Res Pract; 1996 Mar; 192(3):205-9. PubMed ID: 8739466
[TBL] [Abstract][Full Text] [Related]
60. Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms.
Karamitopoulou E; Perentes E; Melachrinou M; Maraziotis T
Acta Neuropathol; 1993; 85(3):316-22. PubMed ID: 7681617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
